"ValiMed features patent-pending technology that validates in seconds the strength of compounded doses of high risk medications prior to dispensing. Verification of compounding accuracy and sterilization is a requirement under USP 27-NF 22 Chapter 797, which regulates the compounding of sterile products. The ValiMed System can play a key role in demonstrating the safety of compounded sterile products (CSPs) under these requirements."
Q: How can The Valimed System play a key role in demonstrating the safety of compounded sterile products (CSP) under these requirements?
A: Refer to the first sentence (topic sentence) in the paragraph.
There would be less room for misinterpretaion if the first sentence read:
"Valimed features patent-pending technology that validates in seconds the strength of compounded doses of sterile, high risk medications prior to dispensing.
But it was not meant to be, so it is assumed that Valimed is testing sterile product otherwise it is all for naught.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.